Last 48 quarters of trend data · Healthcare · Drug Manufacturers - Specialty & Generic
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Kamada Ltd.'s quarterly P/E stands at 29.8x, up 26.2% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has expanded 60.8% YoY to 10.9x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 19.43 | 29.79 | 29.92 | 19.28 | 14.90 | 23.61 | 21.75 | 19.18 | 15.50 | 34.38 | 16.52 | 22.70 | 33.25 |
| — | +26.2% | +37.5% | +0.5% | -3.8% | -31.3% | +31.6% | -15.5% | -53.4% | — | +7.3% | -79.9% | — | |
| P/S Ratio | 2.30 | 2.72 | 2.44 | 2.17 | 2.46 | 2.13 | 2.12 | 1.77 | 1.62 | 2.14 | 2.41 | 1.89 | 1.58 |
| — | +28.0% | +14.7% | +22.4% | +52.1% | -0.5% | -12.0% | -6.1% | +2.2% | +26.1% | +144.0% | +11.6% | -24.1% | |
| P/B Ratio | 1.56 | 1.90 | 1.62 | 1.54 | 1.69 | 1.49 | 1.28 | 1.16 | 1.09 | 1.31 | 1.44 | 1.20 | 1.34 |
| — | +27.8% | +26.7% | +32.6% | +54.8% | +13.6% | -11.4% | -3.5% | -18.4% | +9.9% | +41.1% | -4.9% | +17.0% | |
| P/FCF | 24.49 | — | 21.94 | 14.95 | 18.30 | — | 11.08 | 3.69 | 6.26 | — | 36.10 | — | 76.86 |
| — | — | +98.0% | +305.5% | +192.2% | — | -69.3% | — | -91.9% | — | +363.1% | — | +1497.5% | |
| EV / EBITDA | 8.53 | 10.90 | 12.63 | 7.51 | 8.90 | 6.78 | 7.19 | 6.90 | 6.38 | 9.72 | 12.74 | 7.95 | 10.12 |
| — | +60.8% | +75.7% | +8.9% | +39.5% | -30.3% | -43.6% | -13.3% | -36.9% | -34.8% | +115.7% | -14.5% | -83.6% | |
| EV / EBIT | 13.37 | 21.11 | 18.60 | 13.20 | 16.20 | 11.36 | 24.92 | 14.31 | 12.22 | 27.23 | 15.31 | 16.22 | 25.19 |
| — | +85.8% | -25.4% | -7.8% | +32.6% | -58.3% | +62.7% | -11.8% | -51.5% | — | +20.8% | -78.1% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Kamada Ltd.'s operating margin was 15.4% in Q1 2026, up 7.4 pp QoQ and down 2.3 pp YoY. The trailing four-quarter average of 13.9% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 10.4% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.3% | 42.3% | 38.0% | 42.0% | 42.3% | 47.1% | 43.7% | 41.3% | 44.6% | 44.4% | 39.6% | 39.0% | 38.6% |
| — | -10.4% | -13.0% | +1.8% | -5.2% | +6.2% | +10.4% | +5.8% | +15.7% | +15.1% | +17.6% | -2.3% | +25.6% | |
| Operating Margin | 14.5% | 15.4% | 7.9% | 16.6% | 15.8% | 17.7% | 13.0% | 12.7% | 13.3% | 10.7% | 7.6% | 11.5% | 7.0% |
| — | -13.2% | -38.9% | +31.1% | +19.0% | +65.5% | +70.9% | +10.1% | +89.0% | +1037.3% | -13.8% | +44.8% | +172.3% | |
| Net Margin | 11.2% | 9.1% | 8.0% | 11.3% | 16.5% | 9.0% | 9.8% | 9.3% | 10.4% | 6.3% | 13.9% | 8.5% | 4.8% |
| — | +1.4% | -18.3% | +21.7% | +58.2% | +43.7% | -29.7% | +8.9% | +115.3% | +206.4% | +114.3% | +465.6% | +129.1% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 7.6% | 1.6% | 1.3% | 2.0% | 2.9% | 1.6% | 1.5% | 1.5% | 1.8% | 1.0% | 2.1% | 1.6% | 1.0% |
| — | +0.9% | -9.9% | +32.2% | +62.0% | +60.8% | -29.4% | -1.7% | +72.6% | +193.5% | +24.1% | +452.0% | +145.6% | |
| ROA | 5.4% | 1.1% | 0.9% | 1.4% | 2.0% | 1.1% | 1.1% | 1.1% | 1.3% | 0.7% | 1.5% | 1.0% | 0.6% |
| — | +2.3% | -10.5% | +29.2% | +55.7% | +56.6% | -28.0% | +11.2% | +122.1% | +219.7% | +59.4% | +537.6% | +144.5% | |
| ROIC | 9.9% | 2.4% | 1.3% | 2.9% | 2.7% | 3.1% | 2.0% | 2.0% | 2.1% | 1.5% | 1.1% | 1.8% | 1.1% |
| — | -23.8% | -34.1% | +43.1% | +31.1% | +105.9% | +84.0% | +12.1% | +81.1% | +1050.2% | -42.1% | +52.0% | +213.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Kamada Ltd.'s Debt/EBITDA ratio is 1.1x, down from 1.6x last quarter — comfortably within a safe range.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.02 | 0.12 |
| — | +1.9% | +0.8% | -1.1% | +28.9% | +24.2% | +17.9% | +78.0% | -71.6% | -72.7% | -69.1% | -80.7% | -11.0% | |
| Debt / EBITDA | 0.28 | 1.08 | 1.57 | 0.99 | 1.06 | 0.97 | 1.21 | 1.31 | 0.97 | 1.20 | 1.47 | 0.78 | 3.64 |
| — | +10.7% | +30.5% | -24.2% | +9.4% | -19.0% | -18.2% | +68.5% | -73.5% | -82.0% | -49.7% | -80.1% | -87.9% | |
| Current Ratio | 4.07 | 3.33 | 4.07 | 4.03 | 4.00 | 3.30 | 3.73 | 4.84 | 4.07 | 4.25 | 3.43 | 4.11 | 1.97 |
| — | +0.9% | +9.1% | -16.7% | -1.6% | -22.2% | +8.9% | +17.7% | +106.6% | +123.8% | +86.6% | +110.2% | -17.5% | |
| Quick Ratio | 2.28 | 1.90 | 2.28 | 2.24 | 2.21 | 1.93 | 2.14 | 2.73 | 2.14 | 1.98 | 1.64 | 2.13 | 0.75 |
| — | -1.4% | +6.8% | -17.9% | +3.1% | -2.3% | +30.0% | +28.3% | +185.5% | +165.0% | +87.1% | +137.0% | -31.0% | |
| Interest Coverage | 28.16 | 29.68 | 19.28 | 29.81 | 30.96 | 35.44 | 14.01 | 24.63 | 31.96 | 16.34 | — | 9.16 | 5.34 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying KMDA stock.
Kamada Ltd.'s current P/E is 19.4x. The average P/E over the last 4 quarters is 23.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Kamada Ltd.'s current operating margin is 14.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Kamada Ltd.'s business trajectory between earnings reports.